Overview

  • Product name
    Isotetrandrine
  • Description
    Cell-permeable PLA2 inhibitor
  • Biological description
    Cytoplasmic phospholipase A2 (PLA2) inhibitor. Also shown to inhibit α1 adrenoceptor (Ki = 1.6 μM). Cell-permeable. Active in vivo.
  • Purity
    > 98%

Properties

    References for Isotetrandrine (ab141626)

    This product has been referenced in:
    • Chan D  et al. Inhibition of membrane tubule formation and trafficking by isotetrandrine, an antagonist of G-protein-regulated phospholipase A2 enzymes. Mol Biol Cell 15:1871-80 (2004). Read more (PubMed: 14767064) »
    • Catret M  et al. Alpha-adrenoceptor interaction of tetrandrine and isotetrandrine in the rat: functional and binding assays. J Pharm Pharmacol 50:1267-73 (1998). Read more (PubMed: 9877313) »
    • Kondo Y  et al. Selective inhibition of T-cell-dependent immune responses by bisbenzylisoquinoline alkaloids in vivo. Int J Immunopharmacol 14:1181-6 (1992). Read more (PubMed: 1452403) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab141626.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

    Sign up